You are viewing: China Oligonucleotide Synthesis Market analysis

The China Oligonucleotide Synthesis Market was valued at $494.6 Million in 2025 and projected to reach to $1237 Million by 2030, representing a compound annual growth rate of 20.1%. China's oligonucleotide synthesis market is poised for exceptional growth, expanding from $494.6 million in 2025 to $1,237.0 million by 2030.

China Oligonucleotide Synthesis Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Oligonucleotide Synthesis Market Trends and Insights

  • This represents a compound annual growth rate of 20.1%, significantly outpacing global trends.
  • China's dominance in pharmaceutical manufacturing, coupled with rising investments in gene therapy and personalized medicine, positions the country as a critical hub for oligonucleotide production and innovation. The market in China is driven by increasing demand for therapeutic oligonucleotides, including antisense oligonucleotides and siRNA-based treatments.
  • China's regulatory environment has become increasingly supportive of advanced therapeutics, attracting both domestic and international biotech companies to establish synthesis capabilities within the country.
  • Government initiatives promoting biotechnology development and the expansion of contract manufacturing organizations (CMOs) further accelerate growth. By 2030, China is expected to consolidate its position as a leading oligonucleotide synthesis hub in Asia Pacific, supported by cost advantages, technical expertise, and growing clinical adoption of oligonucleotide-based therapies across oncology, genetic disorders, and infectious diseases..

Key Market Statistics

  • CAGR (2025-2030) 20.1% CAGR
  • Market Size, 2025 ~USD 494.6 Million
  • Forecast, 2030 ~USD 1237 Million
  • Country China

China Oligonucleotide Synthesis Market Overview

Rapid Market Expansion :

China's oligonucleotide synthesis market is growing at 20.1% CAGR, significantly outpacing the global rate of 18.6%, driven by increased R&D investments and manufacturing capabilities.

Gene Therapy Leadership :

Rising investments in gene therapy and personalized medicine initiatives position China as a key hub for oligonucleotide development and commercialization in Asia-Pacific.

Manufacturing Dominance :

China's established pharmaceutical manufacturing infrastructure and cost-competitive production capabilities make it a preferred destination for oligonucleotide synthesis outsourcing.

Regulatory Support :

Government initiatives promoting biotechnology innovation and streamlined approval pathways for advanced therapeutics accelerate market growth and attract international partnerships.

China Oligonucleotide Synthesis Market Dynamics

  • This trajectory reflects China's strategic positioning as a global biotechnology powerhouse, supported by substantial government funding, academic research excellence, and a growing ecosystem of biotech startups.
  • The country's focus on gene therapy, RNA interference therapeutics, and personalized medicine creates sustained demand for high-quality oligonucleotide synthesis services. Key drivers include increasing collaborations between Chinese pharmaceutical companies and international biotech firms, rising prevalence of genetic disorders, and expanding clinical trial pipelines.
  • Investment in manufacturing infrastructure and technological advancement will further strengthen China's competitive advantage.
  • The market's outperformance relative to global trends underscores China's critical role in the future of oligonucleotide-based therapeutics development and production..

Related Ecosystem

Biotechnology

Top Technologies
    Top Companies

      Key Takeaways

      • China's oligonucleotide synthesis market will grow from $494.6M (2025) to $1,237.0M (2030) at a 20.1% CAGR, driven by gene therapy expansion and CMO investments.
      • China's cost-competitive manufacturing and regulatory support position it as Asia Pacific's leading oligonucleotide synthesis hub by 2030.
      • Rising clinical adoption of antisense and siRNA therapeutics in China fuels demand for advanced synthesis capabilities and contract manufacturing services.
      • Government biotechnology initiatives and international partnerships accelerate China's oligonucleotide market growth and technological advancement.

      Oligonucleotide Synthesis Market Report Scope

      Report Metric Details
      Base Year 2025
      Forecast Period 2025–2030
      Growth Rate CAGR of 18.6% from 2025 to 2030
      Market Size Base Year (Billions) ~USD 10.53 (2025)
      Revenue Forecast (Billions) ~USD 24.7 (2030)
      Segments Covered Product, Type, Application, Disease Type, End User

      China Oligonucleotide Synthesis Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Dna Oligos
      • Equipment
      • Oligonucleotide-Based Drugs
      • Other Synthesized Oligos
      • Primers
      • Probes
      • Reagents & Consumables
      • Rna Oligos
      • Synthesized Oligonucleotides

      By Type

      • Antisense Oligonucleotide-Based-Drugs
      • Custom Oligonucleotides
      • Other Oligonucleotide-Based-Drugs
      • Other Research Applications
      • Pcr
      • Predesigned Oligonucleotides
      • Sequencing
      • Sirna Oligonucleotide-Based-Drugs

      By Application

      • Diagnostic Applications
      • Research Applications
      • Therapeutic Applications

      By Disease Type

      • Neurological Disorders
      • Other Diseases
      • Rare Diseases

      By End User

      • Academic Research Institutes
      • Cros & Cmos
      • Diagnostic Laboratories
      • Hospitals
      • Pharmaceutical & Biotechnology Companies

      Target Audience

      • Pharmaceutical & Biotech Companies : Manufacturers and developers of oligonucleotide therapeutics need China-specific market data to identify manufacturing partners, assess market demand, and plan product launches.
      • Contract Manufacturing Organizations (CMOs) : CMOs operating in or targeting China require detailed market insights to understand capacity demand, pricing trends, and competitive positioning in oligonucleotide synthesis services.
      • Investment & Private Equity Firms : Investors evaluating opportunities in Chinese biotech need comprehensive market analysis to assess growth potential, valuation benchmarks, and risk factors in oligonucleotide sectors.
      • Government & Policy Makers : Chinese regulatory bodies and policy officials use market data to inform biotechnology strategy, funding allocation, and regulatory framework development for gene therapy innovation.
      • Research Institutions & Academics : Universities and research centers in China need market intelligence to align R&D initiatives with commercial opportunities and secure funding for oligonucleotide research programs.

      Key Companies in the China Oligonucleotide Synthesis Market

      CompanyHQOwnershipStrongest segments
      FLUOR CORPORATIONUnited StatesPublic CompanyEnergy Solutions (oil, gas, chemicals, LNG, power, energy transition),Urban Solutions (advanced technologies, life sciences, mining, infrastructure, staffing, maintenance),Mission Solutions (government, nuclear remediation, security, logistics, O&M),

      FLUOR CORPORATION

      Fluor Corporation is a publicly traded engineering and construction company founded in 1912 and headquartered in the United States. With approximately 23,000 employees, the company provides design, engineering, procurement, and construction services across multiple industries.

      Reasons to Buy this Report

      • Market Size & Growth Data : Access precise valuation ($494.6M in 2025) and forecast projections ($1,237M by 2030) specific to China, enabling accurate business planning and investment decisions.
      • Competitive Intelligence : Understand China's 20.1% CAGR advantage over global trends, identifying market dynamics, key players, and competitive positioning within the region.
      • Investment Opportunity Assessment : Evaluate China's pharmaceutical manufacturing dominance and gene therapy investments to identify partnership, acquisition, and expansion opportunities in high-growth segments.
      • Regulatory & Policy Insights : Gain clarity on China-specific regulatory frameworks, government support mechanisms, and approval pathways affecting oligonucleotide product commercialization.
      • Strategic Market Entry : Develop informed go-to-market strategies for China with detailed analysis of market drivers, customer segments, and localization requirements for oligonucleotide solutions.

      Frequently asked questions

      What is the current size of China's oligonucleotide synthesis market?

      China's oligonucleotide synthesis market was valued at $494.6 million in 2025 and is expected to grow to $1,237.0 million by 2030.

      What is the projected growth rate for China's oligonucleotide synthesis market?

      China's oligonucleotide synthesis market is projected to grow at a compound annual growth rate (CAGR) of 20.1% from 2025 to 2030.

      What factors are driving growth in China's oligonucleotide synthesis market?

      Key drivers include increasing demand for gene therapies, expansion of contract manufacturing organizations, supportive regulatory policies, and rising clinical adoption of antisense and siRNA-based therapeutics in China.

      Why is China becoming a major hub for oligonucleotide synthesis?

      China offers cost-competitive manufacturing, advanced technical capabilities, government biotechnology support, and a growing ecosystem of domestic and international biotech companies establishing synthesis operations within the country.

      Which therapeutic areas are driving oligonucleotide demand in China?

      Primary therapeutic areas include oncology, genetic disorders, and infectious diseases, where oligonucleotide-based treatments are gaining clinical adoption and regulatory approval in China.

      RESEARCH METHODOLOGY

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information for analyzing the global oligonucleotide synthesis market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Secondary Research

      Secondary research was used primarily to identify and collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include annual reports, SEC filings, investor presentations, the World Health Organization (WHO), the United States Food and Drug Administration (US FDA), the National Center for Biotechnology Information (NCBI), and regulatory body websites, among others. These sources also provided key information on major players, market classification and segmentation aligned with industry trends, regional and country-level markets, market developments, and technology perspectives.

      Primary Research

      In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's prospects. Primary sources from both the supply and demand sides of the market were interviewed to gather qualitative and quantitative information. The following is a breakdown of the primary respondents:

      Oligonucleotide Synthesis Market Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the oligonucleotide synthesis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:

      Oligonucleotide Synthesis Market : Top-Down and Bottom-Up Approach

      Oligonucleotide Synthesis Market Top Down and Bottom Up Approach

      Data Triangulation

      After determining the overall market size through the estimation process, the total market was segmented into several segments and subsegments. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

      Market Definition

      Oligonucleotide synthesis is the chemical process of creating nucleic acid fragments with specific chemical structures or sequences, of varying sizes, to form a desired product. These fragments, known as oligonucleotides, have several applications in medical and life science research. They can be used for DNA sequencing and amplification, detecting complementary DNA or RNA through hybridization, creating artificial genes, and introducing targeted genetic mutations.

      Oligonucleotides are also used to develop therapeutic drugs. These drugs are chemically synthesized and have different mechanisms of action, such as interfering with gene expression, blocking the production of harmful proteins, or restoring the function of mutated genes.

      Key Stakeholders

      • Pharmaceutical & biotechnology companies
      • Hospitals
      • Diagnostic laboratories
      • Academic researchers and government research organizations
      • Private research institutes
      • Custom oligonucleotide service providers
      • Contract manufacturing organizations (CMOs)
      • Oligonucleotide equipment manufacturers
      • Contract research organizations (CROs)
      • Market research & consulting firms
      • Venture capitalists

      Report Objectives

      • To define, describe, and forecast the global oligonucleotide synthesis market based on the offering, type, application, end user, therapeutic area, and region
      • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall oligonucleotide synthesis market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments with respect to six regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
      • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
      • To analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the oligonucleotide synthesis market
      • To provide information on funding & investment activities, brand/product comparative analysis, vendor valuation, and financial metrics of the oligonucleotide synthesis market

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

      Portfolio Assessment

      • Product Matrix gives a detailed comparison of the product portfolios of the top five companies.

      Geographical Analysis

      • A further breakdown of the Rest of Europe’s oligonucleotide synthesis market into countries
      • A further breakdown of the Rest of Asia Pacific’s oligonucleotide synthesis market into countries
      • A further breakdown of the Rest of Latin America’s oligonucleotide synthesis market into countries
      • A further breakdown of the Rest of Middle East’s oligonucleotide synthesis market into countries

      Company Information

      • Detailed analysis and profiling of additional market players (up to five).

       

      Get the Full Oligonucleotide Synthesis Market Report

      Full forecast, segment splits, and company analysis for all Oligonucleotide Synthesis Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status